Provided by Tiger Fintech (Singapore) Pte. Ltd.

RxSIGHT, INC.

16.26
+0.05000.31%
Post-market: 16.300.0350+0.22%18:59 EDT
Volume:2.11M
Turnover:33.49M
Market Cap:658.38M
PE:-23.02
High:16.56
Open:15.17
Low:15.01
Close:16.21
Loading ...

JP Morgan downgrades RxSight on market, competitive pressures

Investing.com
·
04 Apr

JPMorgan Downgrades RxSight to Underweight From Overweight, Adjusts Price Target to $17 From $40

MT Newswires Live
·
04 Apr

RxSight Cut to Underweight From Overweight by JP Morgan

Dow Jones
·
04 Apr

RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ...

GuruFocus.com
·
04 Apr

RxSight Down Over 38%, On Track for Record Percent Decrease -- Data Talk

Dow Jones
·
04 Apr

Top Calls on Wall Street: Nvidia, Block, Lyft, Best Buy, RH, Zscaler, Ross Stores and More

The Fly
·
03 Apr

Rxsight Inc : Btig Cuts Target Price to $28 From $44

THOMSON REUTERS
·
03 Apr

RxSight Q1 Revenue Miss, Guidance Cut Raise Growth Concerns, BofA Says

MT Newswires Live
·
03 Apr

Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall

Benzinga
·
03 Apr

Rxsight Shares Plunge 41% After Cutting FY 2025 Revenue Forecast

THOMSON REUTERS
·
03 Apr

Sector Update: Health Care

MT Newswires Live
·
03 Apr

RxSight downgraded to Underperform from Buy at BofA

TIPRANKS
·
03 Apr

RxSight Price Target Maintained With a $43.00/Share by Needham

Dow Jones
·
03 Apr

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Alibaba, ExxonMobil

Reuters
·
03 Apr

RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges

Benzinga
·
03 Apr

BUZZ-Rxsight falls after slashing annual revenue forecast

Reuters
·
03 Apr

Rxsight Shares Plunge 24% Premarket After Cutting FY 2025 Revenue Forecast

THOMSON REUTERS
·
03 Apr

RxSight Preliminary Q1 Revenue Increases; Lowers 2025 Revenue Guidance

MT Newswires Live
·
03 Apr

Reported Earlier, RxSight Preliminary Q1 Results: Expects Revenue of $37.9M, Up 28% YoY (Vs. $40.14M Est.); Lowers 2025 Revenue Guidance To $160M–$175M (Vs. $188.9M Est.), Down From $185M–$197M

Benzinga
·
03 Apr

RxSight sees Q1 revenue $37.9M, consensus $47.0M

TIPRANKS
·
03 Apr